Skip to main content

Clinical trial INCB 01158-203

A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors. (INCB01158-203)

Organ solid tumors
Trial status Trial open for recruitment
Trial type
Prospective interventional
Phase Trial phase 1
Academic trial Non
Sponsor Incyte Corporate
EudraCT Identifier 2017-002904-29
Inclusion criteria Metastatic Biopsy mandatory
Last update